U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

European stocks pushed higher on Friday and headed for a weekly gain after days of worries over rising coronavirus cases in parts of the world. Potential good news on the U.S.-China trade front was driving some momentum. The Stoxx Europe 600 index SXXP, +0.45% rose 0.6%, after closing down 0.7%Read More →

More than three years of pre-Brexit uncertainty have taken a heavy toll on the U.K. economy, with gross domestic product some 3% lower than it would have been otherwise, according to most estimates. And the stock market, as measured by the FTSE 100 index UKX, -0.75%, has massively underperformed itsRead More →

After a brutal year for cannabis investors, weed stocks on Tuesday rebounded in the final trading session of 2019. Exchange-traded funds that track cannabis companies jumped more than 5% in Tuesday trading. The Horizons Marjiuana Life Sciences Index ETF HMMJ, +7.10%  gained 7.1%, the ETFMG Alternative Harvest ETF MJ, +5.61%Read More →